Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down - Here's What Happened

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares experienced a 4.2% drop, opening at $72.94 compared to the previous closing of $77.00.
  • Citigroup has restated a "neutral" rating for Eurofins Scient, with an overall average rating of "Hold" assessed by market analysts.
  • The company has solid financial ratios, including a debt-to-equity ratio of 0.77 and a current ratio of 1.26.
  • MarketBeat previews the top five stocks to own by October 1st.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $77.00, but opened at $72.94. Eurofins Scient shares last traded at $72.94, with a volume of 166 shares trading hands.

Wall Street Analyst Weigh In

Separately, Citigroup restated a "neutral" rating on shares of Eurofins Scient in a research note on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold".

View Our Latest Stock Analysis on ERFSF

Eurofins Scient Stock Down 4.2%

The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26. The business's 50-day moving average price is $75.58 and its 200-day moving average price is $65.84.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUROFINS SCIENT Right Now?

Before you consider EUROFINS SCIENT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.

While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.